Description
Used in the treatment of:
- Anemia associated with chronic kidney disease (CKD)
- Chemotherapy-induced anemia in cancer patients
Erypeg 100 contains a pegylated recombinant human erythropoietin that stimulates erythropoiesis, increasing red blood cell production and reducing the need for blood transfusions.



